BeStock  
Stocks › Medical Devices › INMD

InMode INMD

US equityMarket cap rank #3404Medical Devices
$14.01 +$0.02 (+0.14%)
Pre-market · Oct 8, 8:10 am ET · After hours $13.85 -1.12%
Open$13.91
Prev close$13.99
Day range$13.90 – $14.05
Volume512.0K
Market cap$806.19M
P/E (TTM)11.6
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$95.59M0.0% YoY
Operating profit$12.26M-46.4% YoY
Net profit$17.06M-36.2% YoY
Diluted EPS$0.29-31.0% YoY
Free cash flow$20.84M-12.6% YoY
Operating cash flow$21.05M

Revenue, last 8 quarters

$130.2MSep '24$97.9MDec '24$77.9MMar '25$95.6MJun '25$93.2MSep '25$103.9MDec '25$82.0MMar '26$95.6MJun '26

Net profit, last 8 quarters

$51.0MSep '24$82.8MDec '24$18.2MMar '25$26.7MJun '25$21.9MSep '25$27.0MDec '25$11.6MMar '26$17.1MJun '26

Diluted EPS by quarter

0.65Sep '241.14Dec '240.26Mar '250.42Jun '250.34Sep '250.42Dec '250.18Mar '260.29Jun '26

Free cash flow by quarter

$34.0MSep '24$32.2MDec '24$14.0MMar '25$23.9MJun '25$24.3MSep '25$22.1MDec '25$15.2MMar '26$20.8MJun '26

Annual revenue

$206.1MFY20$357.6MFY21$454.3MFY22$492.0MFY23$394.8MFY24$370.5MFY25

Profitability & balance sheet

Gross margin76.5%
Operating margin18.5%
Net margin20.7%
Return on equity12.3%
Return on assets10.9%
Return on invested capital12.2%
Current ratio8.18
Liabilities / assets12.7%
Cash & investments$501.12M
Total debt$4.45M
Net cash (debt)$496.66M
Free cash flow / sales22.0%

Where the revenue comes from

Quarter 2026/Q1

By business line

  • Minimal-Invasive$63.15M 77.0%
  • Non-Invasive$18.04M 22.0%
  • Hands-Free$820,170.00 1.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $95.59M $82.02M $370.50M $103.85M $93.17M
Total Operating Revenue $95.59M $82.02M $370.50M $103.85M $93.17M
Cost of Revenue $24.07M $20.47M $79.53M $22.55M $20.86M
Gross Profit $71.52M $61.55M $290.97M $81.30M $72.31M
Operating Expense $59.26M $51.50M $205.58M $55.31M $51.41M
Selling and Admin Expenses $55.60M $47.95M $192.26M $51.80M $47.87M
-Selling & Marketing Expense $50.82M $42.93M $180.58M $48.41M $44.97M
-General & Admin Expense $4.79M $5.02M $11.69M $3.39M $2.90M
Research & Development $3.66M $3.54M $13.32M $3.51M $3.54M
Operating Profit $12.26M $10.06M $85.39M $25.99M $20.90M
Net Non-Operating Interest Income (Expense) $7.43M $4.30M $24.94M $5.30M $4.72M
Total Other Finance Costs -$7.43M – – – -$4.72M
Pretax Profit $19.69M $14.35M $110.33M $31.29M $25.62M
Tax $2.63M $2.79M $16.50M $4.27M $3.76M
Net Profit $17.06M $11.56M $93.83M $27.03M $21.86M
Profit from Continuing Operations $17.06M $11.56M $93.83M $27.03M $21.86M
Net Income to Parent Company $17.06M $11.56M $93.83M $27.03M $21.86M
Net Income to Common Stockholders $17.06M $11.56M $93.83M $27.03M $21.86M
Basic EPS $0.29 $0.18 $1.45 $0.43 $0.35
Diluted EPS $0.29 $0.18 $1.43 $0.42 $0.34
Non-Operating Interest Income – $4.30M $24.94M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $720.33M $750.84M $766.43M $766.43M $734.61M
Total Current Assets $650.00M $680.78M $698.62M $698.62M $666.29M
Cash and Cash Equivalents & Short-Term Investments $501.12M $537.16M $555.33M $555.33M $532.31M
-Cash and Cash Equivalents $396.17M $394.30M $302.54M $302.54M $252.44M
-Short Term Investments $104.94M $142.86M $252.79M $252.79M $279.87M
Receivables $77.22M $72.21M $49.28M $49.28M $62.58M
-Accounts Receivable $44.56M $40.70M $43.50M $43.50M $38.10M
-Other Receivables $32.66M $31.51M $1.83M $1.83M $24.49M
Inventory $71.66M $71.41M $74.05M $74.05M $71.40M
Total Non-Current Assets $70.34M $70.06M $67.81M $67.81M $68.31M
Net PPE $11.32M $11.23M $10.87M $10.87M $11.16M
-Gross PPE $11.32M $11.23M $15.75M $15.75M $11.16M
Investments and Advances $700,000.00 $700,000.00 $700,000.00 $700,000.00 $700,000.00
Non Current Accounts Receivables $5.69M $5.21M $3.01M $3.01M $2.35M
Non-Current Deferred Assets $52.63M $52.92M $53.23M $53.23M $54.10M
Total Liabilities $91.20M $89.58M $83.23M $83.23M $81.22M
Total Current Liabilities $79.44M $77.35M $70.74M $70.74M $68.33M
Payables $18.79M $16.85M $18.67M $18.67M $16.72M
-Accounts Payable $18.79M $16.85M $17.91M $17.91M $16.72M
Current Deferred Liabilities $15.45M $16.37M $12.09M $12.09M $15.10M
Other Current Liabilities $45.19M $44.13M $15.96M $15.96M $36.51M
Total Non-Current Liabilities $11.76M $12.23M $12.49M $12.49M $12.89M
Long Term Debt and Capital Lease Obligation $4.45M $4.83M $5.01M $5.01M $5.59M
-Long Term Capital Lease Obligation $4.45M $4.83M $5.01M $5.01M $5.59M
Non-Current Deferred Liabilities $2.48M $2.75M $3.04M $3.04M $3.13M
Other Non-Current Liabilities $4.83M $4.66M $4.44M $4.44M $4.17M
Total Equity $629.13M $661.25M $683.20M $683.20M $653.39M
Stockholders' Equity $629.13M $661.25M $683.20M $683.20M $653.39M
-Taxes Receivable – – $3.95M $3.95M –
Prepaid Assets – – $19.96M $19.96M –
-Accumulated Depreciation – – -$4.88M -$4.88M –
-Long Term Equity Investment – – $700,000.00 $700,000.00 –
-Total Tax Payable – – $761,000.00 $761,000.00 –
Current Accrued Expenses – – $1.71M $1.71M –
Short-Term Debt and Capital Lease Obligation – – $3.22M $3.22M –
-Current Capital Lease Obligation – – $3.22M $3.22M –
Current Provisions – – $931,000.00 $931,000.00 –
Capital Stock – – $251,000.00 $251,000.00 –
-Common Stock – – $251,000.00 $251,000.00 –
Additional Paid-In Capital – – $209.62M $209.62M –
Retained Earnings – – $968.53M $968.53M –
Less: Treasury Stock – – $495.27M $495.27M –
Gains/Losses Not Affecting Retained Earnings – – $69,000.00 $69,000.00 –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $21.05M $15.39M $85.26M $22.67M $24.47M
Net cash flow from continuing operations $21.05M $15.39M $85.26M $22.67M $24.47M
Net Income from Continuing Operations $17.06M $11.56M $93.83M $27.03M $21.86M
Depreciation & Depletion & Amortization $179,000.00 $175,000.00 $695,000.00 $174,000.00 $156,000.00
Deferred Tax $295,000.00 $327,000.00 $2.93M $864,000.00 $602,000.00
Other Non-Cash Items $388,000.00 $719,000.00 $498,000.00 -$762,000.00 $3.15M
Change in Working Capital -$1.30M -$621,000.00 -$24.30M -$7.42M -$4.11M
-Change in Receivables -$6.21M -$5.79M -$11.13M -$7.63M -$2.50M
-Change in Inventory -$253,000.00 $2.64M -$14.50M -$2.65M -$3.29M
-Change in Payables and Accrued Expense $1.94M -$1.06M $4.13M $1.19M -$759,000.00
-Change in Other Current Liabilities $4.40M -$388,000.00 $2.16M $4.76M $564,000.00
-Change In Other Working Capital -$1.18M $3.98M -$4.96M -$3.09M $1.87M
Net cash flow from investing $37.68M $109.10M $186.03M $27.22M $11.67M
Net Cash Flow from Continuing Investing Activities $37.68M $109.10M $186.03M $27.22M $11.67M
Net PPE Purchase and Sale -$211,000.00 -$172,000.00 -$972,000.00 -$534,000.00 -$134,000.00
Net Investment Purchase and Sale $37.90M $109.28M $187.00M $27.76M $11.80M
Financing Cash Flow -$56.49M -$32.43M -$126.06M $137,000.00 $249,000.00
Net Cash Flow from Continuing Financing Activities -$56.49M -$32.43M -$126.06M $137,000.00 $249,000.00
Net Common Stock Issuance -$56.51M -$31.24M -$127.44M $0.00 $0.00
Proceeds from Stock Option Exercised $19,000.00 $617,000.00 $1.39M $137,000.00 $249,000.00
Ending Cash Balance $396.17M $394.30M $302.54M $302.54M $252.44M
Net Change in Cash $2.24M $92.06M $145.23M $50.03M $36.38M
Beginning Cash Balance $394.30M $302.54M $155.33M $252.44M $216.24M
Effect of Exchange Rate Changes -$365,000.00 -$311,000.00 $1.98M $72,000.00 -$184,000.00
Free Cash Flow $20.84M $15.21M $84.29M $22.14M $24.33M
Net Other Financing Charges – -$1.80M – – –
Gain/Loss from Continuing Operations – – $15,000.00 $1,000.00 $11,000.00

Discussion

No comments yet — be the first to weigh in on INMD.

Leave a comment

Scroll to Top